
Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.

Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.

IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.

Published: June 4th 2020 | Updated:

Published: August 13th 2020 | Updated: